International award for Strathclyde chemistry lecturer

August 02, 2016

A senior lecturer in Chemistry at the University of Strathclyde has won an international award for achievements in his field, including the development of techniques for diagnosing brain tumours.

Dr Matthew Baker has won the Emerging Leader in Molecular Spectroscopy Award from Spectroscopy magazine for outstanding research into real-life applications of analytical chemistry, including pioneering use of vibrational spectroscopy for clinical diagnostics. This has enabled the development of an accurate, efficient and clinically applicable method of brain tumour diagnosis.

The method is the subject of a prospective spin-out, ClinSpec Dx, from Strathclyde.

Dr Baker's research also has applications in clinical, biomedical, security and defence fields.

Dr Baker, who is from the Fylde district of Lancashire, was selected to receive the award by an independent scientific committee. It will be presented to him by Spectroscopy magazine at the SciX 2016 conference in Minneapolis, where he will also give a plenary lecture.

Dr Baker said: "It is a great honour to be chosen for this award by a committee of such prominent experts.

"There is need for new diagnostics for cancer and my main aim is to translate our spectroscopic technology to help patients."

Dr Baker recently co-formed the UK Clinical Infrared and Raman Spectroscopy (CLIRSPEC) Network. This has also produced a charitable organisation, the International Society for Clinical Spectroscopy, which aims to enable promising vibrational spectroscopy methods to be brought into the clinic. He has contributed to numerous key research papers in spectroscopy field, co-written an e-book for the Institute of Physics and guest edited issues of the journals Vibrational Spectroscopy, Journal of Biophotonics and Chemical Society Reviews. He has also developed the successful CLIRSPEC Summer School. This is now in its second year and further raises the profile and reach of clinical spectroscopy through providing an interdisciplinary education to a broad range of students interested in the field. Dr Baker's research was initially funded by Brain Tumour North West (BTNW), the Rosemere Cancer Foundation and the Sydney Driscoll Neuroscience Foundation.

University of Strathclyde

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to